NASDAQ : NRIX

Nurix Therapeutics, Inc. — Stock Grades

$23.77 USD

-$0.38 (-1.57%)

Volume
46.51K
Average Volume
2.02M
Market Capitalization
$2.47B
P/E Ratio
-6.89
Dividend Yield
0.00%
Price Target
$34.00
Year High
$25.09
Year Low
$8.20
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$6.34
NRIX Stock Grades
Date Grading Company Previous Grade New Grade Action
2026-07-22 UBS Buy Buy Maintain
2026-07-13 Mizuho Outperform Outperform Maintain
2026-07-10 Needham Buy Buy Maintain
2026-07-10 BTIG Buy Buy Maintain
2026-07-10 RBC Capital Outperform Outperform Maintain
2026-07-10 Stifel Buy Buy Maintain
2026-07-10 HC Wainwright & Co. Buy Buy Maintain
2026-07-10 Truist Securities Buy Buy Maintain
2026-06-18 Baird Outperform Outperform Maintain
2026-06-15 Needham Buy Buy Maintain
2026-06-10 HC Wainwright & Co. Buy Buy Maintain
2026-06-09 BTIG Buy Buy Maintain
2026-06-09 Truist Securities Buy Buy Maintain
2026-06-08 Wells Fargo Overweight Overweight Maintain
2026-06-08 Needham Buy Buy Maintain
2026-06-08 Jefferies Buy Buy Maintain
2026-05-18 BTIG Buy Buy Maintain
2026-04-27 HC Wainwright & Co. Buy Buy Maintain
2026-04-23 Needham Buy Buy Maintain
2026-04-10 HC Wainwright & Co. Buy Buy Maintain
2026-04-09 Wells Fargo Overweight Overweight Maintain
2026-04-08 Needham Buy Buy Maintain
2026-03-24 HC Wainwright & Co. Buy Buy Maintain
2026-01-29 RBC Capital Outperform Outperform Maintain
2026-01-29 Piper Sandler Overweight Overweight Maintain
2026-01-29 Stifel Buy Buy Maintain
2026-01-29 HC Wainwright & Co. Buy Buy Maintain
2026-01-29 Wells Fargo Overweight Overweight Maintain
2026-01-29 BTIG Buy Buy Maintain
2026-01-29 Needham Buy Buy Maintain
2026-01-08 Morgan Stanley Equal Weight Overweight Upgrade